Osaka, Japan

Shimon Sakaguchi

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Osaka, JP (2020 - 2022)
  • Suita, JP (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Shimon Sakaguchi: Innovator in Cancer Treatment

Introduction

Shimon Sakaguchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies. With a total of 5 patents to his name, Sakaguchi's work has the potential to impact the lives of many patients.

Latest Patents

Sakaguchi's latest patents include groundbreaking inventions such as the "Anti-CTLA-4 antibody and use thereof." This patent provides anti-CTLA-4 antibodies along with methods for producing and utilizing these antibodies. Additionally, it includes nucleic acids encoding the antibodies and host cells containing these nucleic acids. Another notable patent is the "Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells." This invention offers a pharmaceutical composition for cancer treatment that comprises an antibody against CCR8.

Career Highlights

Throughout his career, Shimon Sakaguchi has worked with esteemed institutions such as Osaka University and Shionogi & Company Limited. His research has focused on developing innovative solutions for cancer treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Sakaguchi has collaborated with notable colleagues, including Atsushi Tanaka and Tetsuya Yoshida. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Shimon Sakaguchi's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…